A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease

Gastroenterology

Volumn 114, Issue 6, 1998, Pages 1133-1142

  Yacyshyn, B R ^a   Bowen Yacyshyn, M B ^a   Jewell, L ^a   Tami, J A ^a   Bennett, C F ^a   Kisner, D L ^a   Shanahan W R , Jr ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTISENSE OLIGONUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INTESTINE MUCOSA; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION;

EID: 0031782392     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70418-4     Document Type: Article

References (53)

1. ML Dustin R Rothlein AK Bhan CA Dinarello TA Springer Induction by IL 1 and interferon gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1) J Immunol 137 1986 245 254
2. RM Rothlein L Dustin SD Marlin TA Springer A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1 J Immunol 137 1986 1270 1274
3. SD Marlin TA Springer Purified intercellular adhesion molecule–1 (ICAM-1) is a ligand for lymphocyte function associated antigen–1 (LFA-1) Cell 51 1987 813 819
4. MS Diamond DE Staunton AR deFougerolles SA Stacker J Garcia-Aguilar ML Hibbs TA Springer ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18) J Cell Biol 111 1990 3129 3139
5. EC Butcher Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity Cell 67 1991 1033 1036
6. MB Furie MCA Tancinco CW Smith Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule–1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro Blood 78 1991 2089 2097
7. N Oppenheimer-Marks LS Davis DT Bogue J Ramberg PE Lipsky Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes J Immunol 147 1991 2913 2921
8. DM Altmann N Hogg J Trowsdale D Wilkinson Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells Nature 338 1989 512 514
9. GA Van Seventer Y Shimizu KJ Horgan S Shaw The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor–mediated activation of resting T cells J Immunol 144 1990 4579 14458
10. ML Entman K Youker T Shoji G Kukielka SB Shappell AA Taylor CW Smith Neutrophil induced oxidative injury of cardiac myocytes J Clin Invest 90 1992 1335 1345
11. + T lymphocytes J Immunol 148 1992 1985 1992
12. J Poudier T Owens CD54/Intercellular adhesion molecule 1 and major histocompatibility complex II signalling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation J Exp Med 179 1994 1417 1427
13. S Montefort ST Holgate Adhesion molecules and their role in inflammation Resp Med 85 1991 91 99
14. C Berlin EL Berg MJ Briskin DP Andrew PJ Kilshaw B Holzman IL Weismann A Hamann EC Butcher Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 Cell 74 1993 185 195
15. G Malizia A Calabrese M Cottone M Raimondo LK Trejdosiewicz CJ Smart L Oliva L Pagliaro Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease Gastroenterology 100 1991 150 159
16. H Ohtani S Nakamura Y Watanabe K Fukushima T Mizoi M Kimura N Hiwatashi H Nagura Light and electron microscopic immunolocalization of endothelial leukocyte adhesion molecule–1 in inflammatory bowel disease Virchows Arch A Pathol Anat Histopathol 420 1992 403 409
17. S Nakamura H Ohtani Y Wanatabe K Fukushima T Matsumoto A Kitano K Kobayashi H Nagura In situ expression of the cell adhesion molecules in inflammatory bowel disease: evidence of immunologic activation of vascular endothelial cells Lab Invest 69 1993 77 85
18. BR Yacyshyn A Lazarovits V Tsai K Matejko Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns Gastroenterology 107 1994 1364 1371
19. CN Bernstein M Sargent WM Gallatin J Wilkins β2 integrin/intercellular adhesion molecule (ICAM) expression in the normal intestine Clin Exp Immunol 106 1996 160 169
20. R Hokari S Miura H Fujimoro H Nagata E Sekizuka Y Tsuzuki I Kurose H Serizawa M Suematsu H Yagita DN Granger H Ishii Lymphocyte outflux to intestinal microlymphatics is an intercellular adhesion molecule–1 dependent process in Peyer's patches (abstr) Gastroentrology 112 1997 A369
21. J Meenan J Spaans TA Grool ST Pals GNJ Tytgat SJH van Deventer Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation Gut 40 1997 241 246
22. CF Bennett T Condon S Grimm H Chan MY Chiang Inhibition of endothelial cell–leukocyte adhesion molecule expression with antisense oligonucleotides J Immunol 152 1994 3530 3540
23. F Nestle RS Mitra CF Bennett BJ Nickoloff Cationic lipid is not required for uptake and inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotide in keratinocytes J Invest Dermatol 103 1994 569 575
24. MY Chiang H Chan MA Zounes SM Freier WF Lima CF Bennett Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms J Biol Chem 266 1991 18162 18171
25. CF Bennett ST Crooke Regulation of endothelial cell adhesion molecule expression with antisense oligonucleotides Adv Pharmacol 28 1994 1 43
26. E Wickstrom Oligonucleotide stability in subcellular extracts and culture media J Biochem Biophys Methods 13 1986 97 102
27. GD Hoke K Draper S Freier C Gonzales VB Driver MC Zounes DJ Ecker Effects of phosphorothioate cappping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection Nucleic Acid Res 19 1991 5743 5748
28. ME Mielo CF Bennett BE Miller DR Welch Enhanced metastatic ability of TNF-α treated malignant melanoma cells is reduced by intercellular adhesion molecule–1 (CD54) antisense olgonucleotides Exp Cell Res 214 1994 231 241
29. M Christofidou-Solomidou SM Albelda CF Bennett GF Murphy Experimental production and modulation of human cytotoxic dermatitis in human-murine chimeras Am J Pathol 150 1997 631 639
30. SM Stepkowski Y Tu TP Condon CF Bennett Blocking of heart allograft rejection by ICAM-1 antisense oligonucleotides alone or in combination with other immunosuppresive modalities J Immunol 153 1994 5336 5346
31. CF Bennett D Kornbrust S Henry K Stecker R Howard S Cooper S Dutson W Hall HI Jacoby An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium–induced colitis in mice J Pharmacol Exp Ther 280 1997 988 1000
32. T Kumasaka WM Quinlan NA Doyle TP Condon J Sligh F Takei AL Beaudet CF Bennett CM Doerschuk The role of ICAM-1 in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti–ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice J Clin Invest 97 1996 2362 2369
33. RS Geary JM Leeds SP Henry DK Monteith AA Levin Antisense oligonucleotide inhibitors for the treatment of cancer: 11. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides Anticancer Drug Des 12 1997 383 393
34. RS Geary JM Leeds J Fitchett T Burckin L Truong C Spainhour M Creek AA Levin Pharmacokinetics and metabolism of a phosphorothioate oligonucletide antisense inhibitor of c-RAF-1 kinase expression Drug Metab Dispos 25 1997 1272 1281
35. JM Glover JM Leeds TGK Mant D Amin DL Kisner JE Zuckerman RS Geary AA Levin WR Shanahan Phase 1 safety and pharmacokinetic profile of an intercellular adhesion molecule–1 antisense oligonucleotide (ISIS 2302) J Pharmacol Exp Ther 282 1997 1173 1180
36. SP Henry D Monteith AA Levin Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicological properties of phosphorothioate oligodeoxynucleotides Anticancer Drug Des 12 1997 395 408
37. SP Henry H Bolte C Auletta DJ Kornbrust Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in cynomolgus monkeys Toxicology 120 1997 145 155
38. SP Henry PC Giclas J Leeds M Pangburn C Auletta AA Levin DJ Kornbrust Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action J Pharmacol Exp Ther 281 1997 810 816
39. Sheehan JP, Lan HC. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex. Blood (in press).
40. SP Henry R Larkin WF Novotny DJ Kornbrust Effects of ISIS 2302, a phosphorothioate oligonucleotide, on in vitro and in vivo coagulation parameters Pharm Res 11 1994 S-353
41. SP Henry J Taylor L Midgley AA Levin DJ Kornbrust Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice Antisense Nucleic Acid Drug Dev 7 1997 473 481
42. WR Best JM Bectel JW Singleton F Kern Development of a Crohn's Disease Activity Index: National Cooperative Crohn's Disease Study Gastroenterology 70 1976 439 444
43. WR Best JM Bectel JW Singleton Rederived values of the eight coefficients of the Crohn's Disease Activity Index Gastroenterology 77 1979 483 486
44. X Ma DJ Lefer AM Lefer R Rothlein Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule–1 in myocardial ischemia and reperfusion Circulation 86 1992 937 946
45. JY Mary R Modigliani Development and validation of a Crohn's disease endoscopic index: a prospective multicentric study Gut 30 1989 983 989
46. G Guyatt A Mitchell EJ Irvine J Singer N Williams R Goodacre C Tompkins A new measure of health status for clinical trials in inflammatory bowel disease Gastroenterolgy 96 1989 804 810
47. EJ Irvine B Feagan J Rochon A Archambault RN Fedorak A Groll D Kinnear F Siabil JW McDonald Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease Gastroenterology 106 1994 287 296
48. JM Leeds MJ Graham L Truong LL Cummins Quantitation of phosphorothioate oligonucleotides in human plasma Anal Biochem 235 1996 36 43
49. P Kuhlman VT Moy BA Lollo AA Brian The accessory function of murine intercellular adhesion molecule–1 in T lymphocyte activation J Immunol 146 1991 1773 1782
50. MW Makgoba ME Sanders GEG Luce EA Gugel ML Dustin TA Springer S Shaw Functional evidence that intercellular adhesion molecule–1 (ICAM-1) is a ligand for LFA-1–dependent adhesion in T cell–mediated cytotoxicity Eur J Immunol 18 1988 637 640
51. P Allavena C Paganin I Martin-Padura G Peri M Gaboli E Dejana PC Marchisio A Mantovani Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium J Exp Med 173 1991 439 448
52. M Isobe H Yaghita K Okumura A Ihara Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1 Science 255 1992 1125 1127
53. LS Davis AF Kavanaugh LA Nichols PE Lipsky Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis J Immunol 154 1995 3525 3537